Literature DB >> 28641460

Variability in strength of red yeast rice supplements purchased from mainstream retailers.

Pieter A Cohen1,2, Bharathi Avula3, Ikhlas A Khan3.   

Abstract

The United States Food and Drug Administration (FDA) has introduced manufacturing standards for dietary supplements, including red yeast rice, to assure their identity, purity, strength, and composition. One supplement commonly used to self-treat high cholesterol, red yeast rice, may contain monacolin K, an ingredient identical to prescription lovastatin. We examined whether FDA's manufacturing standards led to standard concentrations of the statin monacolin K in red yeast rice supplements. We analyzed 28 brands of red yeast rice supplements by ultra-high performance liquid chromatography-diode array detector-quadrupole time-of-flight mass spectrometry for monacolin K content. Monacolin K was not detected in two brands. In the 26 brands that contained monacolin K, the quantity ranged more than 60-fold from 0.09 to 5.48 mg per 1200 mg of red yeast rice. Following the manufacturers' recommendations for daily servings, the quantity of monacolin K consumed per day would range more than 120-fold from 0.09 to 10.94 mg. Despite FDA manufacturing standards, strength and composition of red yeast rice supplements sold at mainstream retail stores in the United States remains unpredictable.

Entities:  

Keywords:  Primary prevention; red yeast rice

Mesh:

Substances:

Year:  2017        PMID: 28641460     DOI: 10.1177/2047487317715714

Source DB:  PubMed          Journal:  Eur J Prev Cardiol        ISSN: 2047-4873            Impact factor:   7.804


  7 in total

1.  Acute liver injury induced by red yeast rice supplement.

Authors:  Lize Loubser; Kirstin I Weider; Sean M Drake
Journal:  BMJ Case Rep       Date:  2019-03-25

2.  Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.

Authors:  Emanuel Raschi; Anna Girardi; Elisabetta Poluzzi; Emanuele Forcesi; Francesca Menniti-Ippolito; Gabriela Mazzanti; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.606

3.  Red Yeast Rice: A Systematic Review of the Traditional Uses, Chemistry, Pharmacology, and Quality Control of an Important Chinese Folk Medicine.

Authors:  Bo Zhu; Fangyuan Qi; Jianjun Wu; Guoqing Yin; Jinwei Hua; Qiaoyan Zhang; Luping Qin
Journal:  Front Pharmacol       Date:  2019-12-02       Impact factor: 5.810

4.  Evaluating Risk of Incident Diabetes Between Patients Who Used Lovastatin and Red Yeast Rice Prescriptions (LipoCol Forte): A Retrospective Cohort Study Based on a Real-World Database.

Authors:  Ta-Liang Chen; Chun-Chuan Shih; Chao-Shun Lin; Jui-An Lin; Chun-Chieh Yeh; Li-Chin Sung; Yi-Cheng Chang; Chien-Chang Liao
Journal:  Diabetes Metab Syndr Obes       Date:  2020-01-09       Impact factor: 3.168

5.  Perspectives on Functional Red Mold Rice: Functional Ingredients, Production, and Application.

Authors:  Feng Yanli; Yu Xiang
Journal:  Front Microbiol       Date:  2020-11-25       Impact factor: 5.640

6.  Risk Assessment of RYR Food Supplements: Perception vs. Reality.

Authors:  Laura Righetti; Chiara Dall'Asta; Renato Bruni
Journal:  Front Nutr       Date:  2021-12-07

7.  Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia.

Authors:  Maciej Banach; Niki Katsiki; Gustavs Latkovskis; Manfredi Rizzo; Daniel Pella; Peter E Penson; Zeljko Reiner; Arrigo F G Cicero
Journal:  Arch Med Sci       Date:  2021-03-04       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.